Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
NCT04545788
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
DRUG:
Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine.
Sponsor
Beijing Chest Hospital